









Markets
/
Stocks
/
nasdaq-mck
/

Mckesson Corp

MCK



View Detailed Chart

711.420USD

-8.850-1.23%

Close 09/12, 16:00（ET）Quotes delayed by 15 min

89.64BMarket Cap

28.33P/E TTM



Mckesson Corp

711.420

-8.850-1.23%

Overview Company Financials Analysis

Analysis

Intraday

30m

Today

-1.23%

5 Days

+3.49%

1 Month

+5.58%

6 Months

+9.38%

Year to Date

+24.83%

1 Year

+37.13%

View Detailed Chart

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

17 / 176

Overall Ranking

112 / 4724

Industry

Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 18 analysts

Buy

Current Rating

785.731

Target Price

+10.45%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

McKesson Corporation is a provider of diversified healthcare services. It is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 359.05B.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 29.76% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 10.68%.

Overvalued

The company’s latest PE is 28.35, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 111.75M shares, decreasing 2.40% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 12.01M shares of this stock.